Description

CITA-VAZ 10mg Tablets contain Escitalopram, an SSRI antidepressant prescribed for major depressive disorder and generalized anxiety disorder.

Escitalopram selectively inhibits serotonin reuptake, helping regulate neurotransmission associated with mood and anxiety.

The 10mg strength is the usual adult starting and recommended dose for major depressive disorder and generalized anxiety disorder under U.S. prescribing information.

Clinical response generally develops over time, and continued treatment requires monitoring by a healthcare professional.

Therapeutic Indications

  • Major depressive disorder.

  • Generalized anxiety disorder.

U.S. prescribing information also includes certain pediatric age groups, but their applicability to CITA-VAZ must be confirmed against its Pakistan-approved labeling.

Dosage & Administration

For adults, the reference starting dosage is 10mg once daily.

Depending on response and tolerability, the physician may increase the dosage to 20mg daily after at least one week. For most older adults and patients with hepatic impairment, the recommended reference dosage is 10mg daily.

Side effects

Nausea, insomnia, headache, fatigue, sleepiness, increased sweating, decreased libido and other sexual dysfunction.

Contraindications & Precautions

Do not combine with contraindicated MAO inhibitors, including Linezolid without an appropriate specialist-managed treatment plan, or with pimozide.

Important warnings include suicidal thoughts and behaviours in younger patients, serotonin syndrome, abnormal bleeding, low sodium, activation of mania and discontinuation symptoms.

Patients should not stop treatment abruptly without medical advice.